Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Ruppé E[au]:

Search results

Items: 1 to 50 of 79

1.

Structure-based classification of class A beta-lactamases, an update.

Philippon A, Jacquier H, Ruppé E, Labia R.

Curr Res Transl Med. 2019 May 31. pii: S2452-3186(19)30021-2. doi: 10.1016/j.retram.2019.05.003. [Epub ahead of print] Review.

PMID:
31155436
2.

Messages from the third International Conference on Clinical Metagenomics (ICCMg3).

Ruppé E, Schrenzel J.

Microbes Infect. 2019 Mar 2. pii: S1286-4579(19)30026-7. doi: 10.1016/j.micinf.2019.02.004. [Epub ahead of print]

PMID:
30836173
3.

The intestinal microbiota predisposes to traveler's diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.

Leo S, Lazarevic V, Gaïa N, Estellat C, Girard M, Matheron S, Armand-Lefèvre L, Andremont A The VOYAG-R study group, Schrenzel J, Ruppé E.

Gut Microbes. 2019 Feb 3:1-11. doi: 10.1080/19490976.2018.1564431. [Epub ahead of print]

PMID:
30714464
4.

Rationalizing antimicrobial therapy in the ICU: a narrative review.

Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodríguez-Baño J, Ruppé É, Salluh J, Taccone FS, Weiss E, Barbier F.

Intensive Care Med. 2019 Feb;45(2):172-189. doi: 10.1007/s00134-019-05520-5. Epub 2019 Jan 18. Review.

PMID:
30659311
5.

The challenges of designing a benchmark strategy for bioinformatics pipelines in the identification of antimicrobial resistance determinants using next generation sequencing technologies.

Angers-Loustau A, Petrillo M, Bengtsson-Palme J, Berendonk T, Blais B, Chan KG, Coque TM, Hammer P, Heß S, Kagkli DM, Krumbiegel C, Lanza VF, Madec JY, Naas T, O'Grady J, Paracchini V, Rossen JWA, Ruppé E, Vamathevan J, Venturi V, Van den Eede G.

Version 2. F1000Res. 2018 Apr 13 [revised 2018 Jan 1];7. pii: ISCB Comm J-459. doi: 10.12688/f1000research.14509.2. eCollection 2018. Review.

6.

Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.

Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N; VOYAG-R study group, Matheron S, Andremont A, Armand-Lefevre L.

PLoS One. 2018 Dec 18;13(12):e0206909. doi: 10.1371/journal.pone.0206909. eCollection 2018.

7.

Prediction of the intestinal resistome by a three-dimensional structure-based method.

Ruppé E, Ghozlane A, Tap J, Pons N, Alvarez AS, Maziers N, Cuesta T, Hernando-Amado S, Clares I, Martínez JL, Coque TM, Baquero F, Lanza VF, Máiz L, Goulenok T, de Lastours V, Amor N, Fantin B, Wieder I, Andremont A, van Schaik W, Rogers M, Zhang X, Willems RJL, de Brevern AG, Batto JM, Blottière HM, Léonard P, Léjard V, Letur A, Levenez F, Weiszer K, Haimet F, Doré J, Kennedy SP, Ehrlich SD.

Nat Microbiol. 2019 Jan;4(1):112-123. doi: 10.1038/s41564-018-0292-6. Epub 2018 Nov 26.

PMID:
30478291
8.

Focus on sepsis: new concepts and findings in sepsis care.

Timsit JF, Ruppe E, Ferrer R.

Intensive Care Med. 2018 Nov;44(11):1997-1999. doi: 10.1007/s00134-018-5406-3. Epub 2018 Oct 10. No abstract available.

PMID:
30306194
9.

Carbapenems and alternative β-lactams for the treatment of infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: What impact on intestinal colonisation resistance?

Woerther PL, Lepeule R, Burdet C, Decousser JW, Ruppé É, Barbier F.

Int J Antimicrob Agents. 2018 Dec;52(6):762-770. doi: 10.1016/j.ijantimicag.2018.08.026. Epub 2018 Aug 31. Review.

PMID:
30176355
10.

Molecular characterization of fluoroquinolones, macrolides, and imipenem resistance in Haemophilus influenzae: analysis of the mutations in QRDRs and assessment of the extent of the AcrAB-TolC-mediated resistance.

Cherkaoui A, Gaïa N, Baud D, Leo S, Fischer A, Ruppe E, François P, Schrenzel J.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2201-2210. doi: 10.1007/s10096-018-3362-z. Epub 2018 Aug 25.

PMID:
30145620
11.

Author Correction: Abundance and diversity of the faecal resistome in slaughter pigs and broilers in nine European countries.

Munk P, Knudsen BE, Lukjancenko O, Duarte ASR, Van Gompel L, Luiken REC, Smit LAM, Schmitt H, Garcia AD, Hansen RB, Petersen TN, Bossers A, Ruppé E, Lund O, Hald T, Pamp SJ, Vigre H, Heederik D, Wagenaar JA, Mevius D, Aarestrup FM; EFFORT Group.

Nat Microbiol. 2018 Oct;3(10):1186. doi: 10.1038/s41564-018-0241-4.

PMID:
30131524
12.

When Bacterial Culture Fails, Metagenomics Can Help: A Case of Chronic Hepatic Brucelloma Assessed by Next-Generation Sequencing.

Lazarevic V, Gaïa N, Girard M, Leo S, Cherkaoui A, Renzi G, Emonet S, Jamme S, Ruppé E, Vijgen S, Rubbia-Brandt L, Toso C, Schrenzel J.

Front Microbiol. 2018 Jul 17;9:1566. doi: 10.3389/fmicb.2018.01566. eCollection 2018.

13.

Abundance and diversity of the faecal resistome in slaughter pigs and broilers in nine European countries.

Munk P, Knudsen BE, Lukjancenko O, Duarte ASR, Van Gompel L, Luiken REC, Smit LAM, Schmitt H, Garcia AD, Hansen RB, Petersen TN, Bossers A, Ruppé E; EFFORT Group, Lund O, Hald T, Pamp SJ, Vigre H, Heederik D, Wagenaar JA, Mevius D, Aarestrup FM.

Nat Microbiol. 2018 Aug;3(8):898-908. doi: 10.1038/s41564-018-0192-9. Epub 2018 Jul 23. Erratum in: Nat Microbiol. 2018 Oct;3(10):1186.

PMID:
30038308
14.

The gut microbiota of critically ill patients: first steps in an unexplored world.

Ruppé É, Lisboa T, Barbier F.

Intensive Care Med. 2018 Sep;44(9):1561-1564. doi: 10.1007/s00134-018-5309-3. Epub 2018 Jul 14. No abstract available.

PMID:
30008112
15.

What's new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation.

Ruppé E, Martin-Loeches I, Rouzé A, Levast B, Ferry T, Timsit JF.

Clin Microbiol Infect. 2018 Aug;24(8):803-805. doi: 10.1016/j.cmi.2018.05.020. Epub 2018 Jun 2. No abstract available.

PMID:
29870851
16.

Travel and acquisition of multidrug-resistant Enterobacteriaceae.

Armand-Lefèvre L, Andremont A, Ruppé E.

Med Mal Infect. 2018 Oct;48(7):431-441. doi: 10.1016/j.medmal.2018.02.005. Epub 2018 Mar 14. Review.

PMID:
29550142
17.

Messages from the second International Conference on Clinical Metagenomics (ICCMg2).

Ruppé E, Schrenzel J.

Microbes Infect. 2018 Apr;20(4):222-227. doi: 10.1016/j.micinf.2018.02.005. Epub 2018 Mar 8.

PMID:
29524500
18.

In-depth resistome analysis by targeted metagenomics.

Lanza VF, Baquero F, Martínez JL, Ramos-Ruíz R, González-Zorn B, Andremont A, Sánchez-Valenzuela A, Ehrlich SD, Kennedy S, Ruppé E, van Schaik W, Willems RJ, de la Cruz F, Coque TM.

Microbiome. 2018 Jan 15;6(1):11. doi: 10.1186/s40168-017-0387-y.

19.

In vivo selection of a multidrug-resistant Aeromonas salmonicida during medicinal leech therapy.

Ruppé E, Cherkaoui A, Wagner N, La Scala GC, Beaulieu JY, Girard M, Frey J, Lazarevic V, Schrenzel J.

New Microbes New Infect. 2017 Oct 10;21:23-27. doi: 10.1016/j.nmni.2017.10.005. eCollection 2018 Jan.

20.

Protection of the Human Gut Microbiome From Antibiotics.

de Gunzburg J, Ghozlane A, Ducher A, Le Chatelier E, Duval X, Ruppé E, Armand-Lefevre L, Sablier-Gallis F, Burdet C, Alavoine L, Chachaty E, Augustin V, Varastet M, Levenez F, Kennedy S, Pons N, Mentré F, Andremont A.

J Infect Dis. 2018 Jan 30;217(4):628-636. doi: 10.1093/infdis/jix604.

21.

Establishing Genotype-to-Phenotype Relationships in Bacteria Causing Hospital-Acquired Pneumonia: A Prelude to the Application of Clinical Metagenomics.

Ruppé E, Cherkaoui A, Lazarevic V, Emonet S, Schrenzel J.

Antibiotics (Basel). 2017 Nov 29;6(4). pii: E30. doi: 10.3390/antibiotics6040030. Review.

22.

Digestive tract colonization by multidrug-resistant Enterobacteriaceae in travellers: An update.

Ruppé E, Andremont A, Armand-Lefèvre L.

Travel Med Infect Dis. 2018 Jan - Feb;21:28-35. doi: 10.1016/j.tmaid.2017.11.007. Epub 2017 Nov 17. Review.

PMID:
29155322
23.

Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis.

Kardaś-Słoma L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppé E, Boëlle PY, Andremont A, Yazdanpanah Y.

BMJ Open. 2017 Nov 3;7(11):e017402. doi: 10.1136/bmjopen-2017-017402.

24.

Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.

Ruppé E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefèvre L.

Clin Microbiol Infect. 2018 Jan;24(1):3-5. doi: 10.1016/j.cmi.2017.09.017. Epub 2017 Sep 29. No abstract available.

25.

Detection of Bacterial Pathogens from Broncho-Alveolar Lavage by Next-Generation Sequencing.

Leo S, Gaïa N, Ruppé E, Emonet S, Girard M, Lazarevic V, Schrenzel J.

Int J Mol Sci. 2017 Sep 20;18(9). pii: E2011. doi: 10.3390/ijms18092011.

26.

Clinical metagenomics of bone and joint infections: a proof of concept study.

Ruppé E, Lazarevic V, Girard M, Mouton W, Ferry T, Laurent F, Schrenzel J.

Sci Rep. 2017 Aug 10;7(1):7718. doi: 10.1038/s41598-017-07546-5.

27.

Erratum to: Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).

Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P.

World J Emerg Surg. 2017 Aug 2;12:35. doi: 10.1186/s13017-017-0147-0. eCollection 2017.

28.

Antimicrobial resistance in the next 30 years, humankind, bugs and drugs: a visionary approach.

Bassetti M, Poulakou G, Ruppe E, Bouza E, Van Hal SJ, Brink A.

Intensive Care Med. 2017 Oct;43(10):1464-1475. doi: 10.1007/s00134-017-4878-x. Epub 2017 Jul 21. Review.

PMID:
28733718
29.

Clinical Metagenomics for the Diagnosis of Hospital-acquired Infections: Promises and Hurdles.

Emonet S, Lazarevic V, Pugin J, Schrenzel J, Ruppé E.

Am J Respir Crit Care Med. 2017 Dec 15;196(12):1617-1618. doi: 10.1164/rccm.201705-0983LE. No abstract available.

PMID:
28679062
30.

What and how should we tell travellers about antimicrobial resistance?

Ruppé E, Chappuis F.

J Travel Med. 2017 Mar 1;24(2). doi: 10.1093/jtm/taw089. No abstract available.

PMID:
28395100
31.

Messages from the first International Conference on Clinical Metagenomics (ICCMg).

Ruppé E, Greub G, Schrenzel J.

Microbes Infect. 2017 Apr - May;19(4-5):223-228. doi: 10.1016/j.micinf.2017.01.005. Epub 2017 Feb 1.

PMID:
28161601
32.

Clonal or not clonal? Investigating hospital outbreaks of KPC-producing Klebsiella pneumoniae with whole-genome sequencing.

Ruppé E, Olearo F, Pires D, Baud D, Renzi G, Cherkaoui A, Goldenberger D, Huttner A, François P, Harbarth S, Schrenzel J.

Clin Microbiol Infect. 2017 Jul;23(7):470-475. doi: 10.1016/j.cmi.2017.01.015. Epub 2017 Jan 29.

33.

Intestinal carriage of Extended Spectrum Beta-Lactamase producing E. coli in women with urinary tract infections, Cameroon.

Djuikoue IC, Woerther PL, Toukam M, Burdet C, Ruppé E, Gonsu KH, Fokunang C, El Mniai A, Larissa K, Pieme AC, Mboupaing MG, Kakam CM, Fogang HK, Andremont A, Ngogang J.

J Infect Dev Ctries. 2016 Oct 31;10(10):1135-1139. doi: 10.3855/jidc.7616.

34.

ESBL-producing Enterobacteriaceae in travellers: doctors beware.

Armand-Lefevre L, Ruppé E, Andremont A.

Lancet Infect Dis. 2017 Jan;17(1):8-9. doi: 10.1016/S1473-3099(16)30417-0. Epub 2016 Oct 14. No abstract available.

PMID:
27751773
35.

Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).

Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P.

World J Emerg Surg. 2016 Jul 15;11:33. doi: 10.1186/s13017-016-0089-y. eCollection 2016. Review. Erratum in: World J Emerg Surg. 2017 Aug 2;12 :35.

36.

Impact of a short exposure to levofloxacin on faecal densities and relative abundance of total and quinolone-resistant Enterobacteriaceae.

Bernard J, Armand-Lefèvre L, Luce E, El Mniai A, Chau F, Casalino E, Andremont A, Ruppé E.

Clin Microbiol Infect. 2016 Jul;22(7):646.e1-4. doi: 10.1016/j.cmi.2016.04.015. Epub 2016 Apr 26.

37.

In 2035, will all bacteria be multidrug resistant? We are not sure.

Laupland KB, Ruppé E, Harbarth S.

Intensive Care Med. 2016 Dec;42(12):2021-2023. doi: 10.1007/s00134-016-4343-2. Epub 2016 Apr 18. No abstract available.

PMID:
27091440
38.

Dissemination of the mcr-1 colistin resistance gene.

Ruppé E, Le Chatelier E, Pons N, Andremont A, Ehrlich SD.

Lancet Infect Dis. 2016 Mar;16(3):290-1. doi: 10.1016/S1473-3099(16)00066-9. No abstract available.

PMID:
26973305
39.

Clinical metagenomics for the management of hospital- and healthcare-acquired pneumonia.

Ruppé E, Baud D, Schicklin S, Guigon G, Schrenzel J.

Future Microbiol. 2016;11(3):427-39. doi: 10.2217/fmb.15.144. Epub 2016 Mar 2.

PMID:
26934540
40.

Escherichia coli Population Structure and Antibiotic Resistance at a Buffalo/Cattle Interface in Southern Africa.

Mercat M, Clermont O, Massot M, Ruppe E, de Garine-Wichatitsky M, Miguel E, Valls Fox H, Cornelis D, Andremont A, Denamur E, Caron A.

Appl Environ Microbiol. 2015 Dec 28;82(5):1459-1467. doi: 10.1128/AEM.03771-15.

41.

Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y.

Infect Control Hosp Epidemiol. 2016 Mar;37(3):272-80. doi: 10.1017/ice.2015.284. Epub 2015 Dec 28.

PMID:
26708383
42.

Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community.

Gosalbes MJ, Vázquez-Castellanos JF, Angebault C, Woerther PL, Ruppé E, Ferrús ML, Latorre A, Andremont A, Moya A.

Antimicrob Agents Chemother. 2015 Nov 9;60(1):507-14. doi: 10.1128/AAC.01528-15. Print 2016 Jan.

43.

Reply to Collignon and Kennedy.

Ruppé E, Armand-Lefèvre L, Estellat C, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Dec 1;61(11):1767. doi: 10.1093/cid/civ705. Epub 2015 Aug 13. No abstract available.

PMID:
26276883
44.

Mechanisms of antimicrobial resistance in Gram-negative bacilli.

Ruppé É, Woerther PL, Barbier F.

Ann Intensive Care. 2015 Dec;5(1):61. doi: 10.1186/s13613-015-0061-0. Epub 2015 Aug 12.

45.

High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S.

Clin Infect Dis. 2015 Aug 15;61(4):593-600. doi: 10.1093/cid/civ333. Epub 2015 Apr 22.

PMID:
25904368
46.

Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.

Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF; De-escalation Study Group.

Clin Microbiol Infect. 2015 Jul;21(7):649.e1-10. doi: 10.1016/j.cmi.2015.03.013. Epub 2015 Apr 13. Erratum in: Clin Microbiol Infect. 2015 Nov;21(11):e81. Whoerter, P-L [corrected to Woerther, P L].

47.

Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.

Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L.

Clin Microbiol Infect. 2015 May;21(5):468.e1-6. doi: 10.1016/j.cmi.2014.12.007. Epub 2014 Dec 26.

48.

Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.

Soubirou JF, Rossi B, Couffignal C, Ruppé E, Chau F, Massias L, Lepeule R, Mentre F, Fantin B.

J Antimicrob Chemother. 2015 May;70(5):1466-72. doi: 10.1093/jac/dku542. Epub 2015 Jan 5.

PMID:
25564564
49.

Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.

Ruppé E, Armand-Lefèvre L, Estellat C, El-Mniai A, Boussadia Y, Consigny PH, Girard PM, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farèse M, Coignard B, Lucet JC, Andremont A, Matheron S.

Euro Surveill. 2014 Apr 10;19(14). pii: 20768.

50.

Enterobacteriaceae bacteremia: risk factors for ESBLPE.

Neulier C, Birgand G, Ruppé É, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A.

Med Mal Infect. 2014 Jan;44(1):32-8. doi: 10.1016/j.medmal.2013.11.003. Epub 2013 Dec 8.

PMID:
24321202

Supplemental Content

Support Center